SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer
Clinical trial NCT03755115 · UNKNOWN
Trial details
- NCT number
- NCT03755115
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2019-10-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.